Differences in background characteristics of patients with chronic hepatitis C who achieved sustained virologic response with interferon-free versus interferon-based therapy and the risk of developing hepatocellular carcinoma after eradication of hepatiti-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Differences in background characteristics of patients with chronic hepatitis C who achieved sustained virologic response with interferon-free versus interferon-based therapy and the risk of developing hepatocellular carcinoma after eradication of hepatiti

Published:2017-01-11 Issue:6 Volume:24 Page:472-476
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Toyoda H.¹,Tada T.¹,Takaguchi K.²,Senoh T.²,Shimada N.³,Hiraoka A.⁴,Michitaka K.⁴,Ishikawa T.⁵,Kumada T.¹

Affiliation:

1. Department of Gastroenterology; Ogaki Municipal Hospital; Ogaki Japan

2. Department of Hepatology; Kagawa Prefectural Central Hospital; Takamatsu Japan

3. Department of Gastroenterology; Otakanomori Hospital; Kashiwa Japan

4. Department of Gastroenterology; Ehime Prefectural Central Hospital; Matsuyama Japan

5. Department of Hepatology; Saiseikai Niigata Daini Hospital; Niigata Japan

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jvh.12665/fullpdf

Reference17 articles.

1. Viral hepatitis C;Poynard;Lancet,2003

2. Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: a long-term observation study of 1643 patients using statistical bias correction with proportional hazard analysis;Ikeda;Hepatology,1999

3. Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C;Imai;Ann Intern Med,1998

4. Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan;Yoshida;Ann Intern Med,1999

5. Efficacy of pegylated interferon alpha-2b and ribavirin treatment on the risk of hepatocellular carcinoma of patients with chronic hepatitis C: a prospective multicenter study;Ogawa;J Hepatol,2013

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of six hepatocellular carcinoma prediction models in Japanese patients after sustained virologic response undergoing rigorous surveillance for hepatocellular carcinoma;Journal of Gastroenterology and Hepatology;2024-01-30

2. Low surveillance receipt in cirrhotic patients with cured HCV: Where are the barriers?;Liver International;2023-04-25

3. Risk Factors Associated With Development of Hepatocellular Carcinoma in Hepatitis C Virus Patients;Hepatitis C - Recent Advances;2023-02-06

4. Integrated Predictors by Propensity Scoring With Tumor Markers and Plasma Levels of microRNA-21-5p, IL-17, and IL-10 Complement Early Detection of Hepatocellular Carcinoma in Patients With Liver Cirrhosis;Technology in Cancer Research & Treatment;2023-01

5. Adherence to regular surveillance visits for hepatocellular carcinoma in patients with chronic hepatitis C virus infection who achieved sustained virologic response;European Journal of Gastroenterology & Hepatology;2022-02-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3